Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | CSTL Castle Biosciences, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $35.81 +1.8% | $14.86 -2.5% |
| StockIQ Score | 57C Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 82A- | 13F |
| Fundamental | 39F | 35F |
| Growth | 34F | 50C- |
| Fair Value | 38F | 38F |
| News | 100A+ | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 54C- | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Castle Biosciences (CSTL) outperforms Ascentage Pharma (AAPG) in technicals (74 vs. 18) and investor sentiment (54 vs. 37), reflecting stronger market trends and confidence. However, AAPG leads in growth potential (50 vs. 34), suggesting faster expansion expectations. Both share similar valuation scores (38), but CSTL’s moderate rating contrasts with AAPG’s weak standing.
